Good morning!
On Friday afternoon we published The Week Ahead including the economic calendar and the company reporting schedule for this week.
Today's Agenda is now complete.
1.30pm: out of time for today, thank you.
Companies Reporting
Name (Mkt Cap) | RNS | Summary | Our view (Author) |
---|---|---|---|
HgCapital Trust (LON:HGT) (£2.42bn) | Annual Financial Report | Software-focused private equity trust. 10.4% NAVps growth. 13% discount moves to 2% premium. | |
Renewables Infrastructure (LON:TRIG) (£1.8bn) | Completion of German Offshore Wind Sell Down | Sold 15.2% stake in Gode One at 9% above book. €100m received & used to reduce RCF to £228m. | |
GlobalData (LON:DATA) (£1.49bn) | Full Year Results | Results in line. Underlying rev growth 4%. PBT +32% (£54.9m). “Robust” outlook, high visibility. | AMBER (Graham) This is likely to be a high-quality business with strong prospects but that's reflected in an already-high valuation. The accounts are complex and may remain so as management focus on their M&A strategy. I'd like to be more positive but am most comfortable with a neutral stance at this time. |
Clarkson (LON:CKN) (£1.36bn) | Preliminary Results | Adj. PBT +6% to £115m. Adj. net cash £216m. Outlook: markets have softened. Market uncertainty. | AMBER (Roland holds) Today’s record 2024 results contrast with a more subdued outlook that has seen broker Panmure cut its estimates for 2025 and 2026. Uncertain prospects for the year ahead mean I’m taking a neutral view now, but I expect Clarkson’s market leadership and proven ability to navigate market cycles to endure over time. |
Assura (LON:AGR) (£1.3bn) | Possible cash offer | KKR has increased its possible cash offer to 49.4p per share, equivalent to 100% of 30/9 NAV. | PINK (Graham) Well done to the Assura board for holding out until they received a bid at tangible NAV or higher. They were also offered the chance to merge with Primary Health Properties (LON:PHP, underlining the attractiveness of their portfolio. Over to KKR now to firm up their bid, and then Assura shareholders can decide if they wish to cash out. |
Alliance Pharma (LON:APH) (£338m) | Final increased recommended cash offer | The buyers have made a final cash offer of 64.75p per share, recommended by the board. | PINK (Roland) [no section below] Today’s improved and final cash offer from buyer DBAY is a 3.6% increase on the 62.5p recommended to shareholders on 10 Jan 25. This increase is the result of “feedback from Alliance shareholders”. We… |